Skip to content

Micropulse 26U Pulse Generator

by Edwards Pacemaker Systems

510(k) K771987

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK771987 Date2 Nov 1977ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
DXY
Device Class
Class III
Regulation
21 CFR Part 870.3610
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Micropulse 26U Pulse Generator is an Implantable Pacemaker Pulse-Generator, a Class III medical device designed to regulate cardiac rhythm by delivering electrical impulses to the heart. It is intended for patients requiring pacing support due to bradycardia or other conduction disorders, ensuring consistent and reliable cardiac function.

This device is supplied as a reusable, non-sterile component within a pacemaker system and must be implanted surgically by a qualified healthcare professional. It operates in a controlled clinical setting and is regulated under FDA 510(k) clearance (K771987) as a high-risk, life-sustaining cardiovascular device. Compliance with regulatory standards ensures proper functionality and patient safety in cardiac pacing applications.

Other devices from Edwards Pacemaker Systems

See all devices from Edwards Pacemaker Systems →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the primary purpose of the Micropulse 26U Pulse Generator in a clinical setting?

    The Micropulse 26U Pulse Generator is designed to regulate cardiac rhythm by delivering electrical impulses to the heart, specifically for patients with bradycardia or conduction disorders. It ensures consistent and reliable cardiac function by providing pacing support in a controlled clinical environment.

  • Is the Micropulse 26U Pulse Generator intended for single-use or can it be reused?

    The Micropulse 26U Pulse Generator is supplied as a reusable component within a pacemaker system. It is not sterile as shipped and must be handled in a sterile surgical setting during implantation by qualified healthcare professionals.

  • How is the regulatory pathway for this device structured, and what does it indicate about its risk level?

    The Micropulse 26U Pulse Generator is classified as a Class III medical device and has obtained FDA 510(k) clearance under the traditional review pathway, with a decision code of 'SESE' (Substantially Equivalent). This classification and clearance indicate it is a high-risk, life-sustaining cardiovascular device, ensuring stringent regulatory oversight for patient safety.

  • What type of medical specialty is primarily responsible for the use and oversight of this device?

    The Micropulse 26U Pulse Generator falls under the medical specialty of Cardiovascular, meaning it is primarily used and overseen by cardiologists, electrophysiologists, and other specialists in cardiac care who manage pacemaker therapy.

  • What does the product code (DXY) and advisory committee designation (CV) signify for this device?

    The product code DXY categorizes this device as an Implantable Pacemaker Pulse-Generator under FDA’s classification system, while the advisory committee designation (CV) indicates it was reviewed by the Cardiovascular (CV) Panel during the 510(k) submission process. This reflects its specialized role in cardiac pacing and the expertise involved in its regulatory evaluation.